These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 17851225

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.
    Giachino DF, Ghio P, Regazzoni S, Mandrile G, Novello S, Selvaggi G, Gregori D, DeMarchi M, Scagliotti GV.
    Clin Cancer Res; 2007 May 15; 13(10):2876-81. PubMed ID: 17504986
    [Abstract] [Full Text] [Related]

  • 23. Adjuvant chemotherapy for non-small cell lung cancer: a New Zealand perspective.
    Sasidharan R, Gibbs D, Sullivan R, Simpson A, Perez D, Christmas T, McKeage M.
    N Z Med J; 2006 Nov 17; 119(1245):U2310. PubMed ID: 17146485
    [Abstract] [Full Text] [Related]

  • 24. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
    Zhai R, Liu G, Zhou W, Su L, Heist RS, Lynch TJ, Wain JC, Asomaning K, Lin X, Christiani DC.
    Clin Cancer Res; 2008 Jan 15; 14(2):612-7. PubMed ID: 18223238
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: the JBR.10 trial experience.
    Gauthier I, Ding K, Winton T, Shepherd FA, Livingston R, Johnson DH, Rigas JR, Whitehead M, Graham B, Seymour L.
    Lung Cancer; 2007 Mar 15; 55(3):357-63. PubMed ID: 17141357
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A single-nucleotide polymorphism in the MDR1 gene as a predictor of response to neoadjuvant chemotherapy in breast cancer.
    George J, Dharanipragada K, Krishnamachari S, Chandrasekaran A, Sam SS, Sunder E.
    Clin Breast Cancer; 2009 Aug 15; 9(3):161-5. PubMed ID: 19661039
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of combination chemotherapy with mitomycin and vinorelbine for the treatment of advanced non-small cell lung cancer.
    Wibmer T, Kropf C, Merk T, Schumann C, Hombach V, Krüger S.
    Lung Cancer; 2008 May 15; 60(2):231-9. PubMed ID: 18006111
    [Abstract] [Full Text] [Related]

  • 31. MDR1 single nucleotide polymorphism C3435T in Turkish patients with non-small-cell lung cancer.
    Dogu GG, Kargi A, Turgut S, Ayada C, Taskoylu BY, Demiray G, Yaren A, Ozlu C, Temel S, Ergin A.
    Gene; 2012 Sep 15; 506(2):404-7. PubMed ID: 22766400
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Vinorelbine--a clinical review.
    Gregory RK, Smith IE.
    Br J Cancer; 2000 Jun 15; 82(12):1907-13. PubMed ID: 10864196
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Vinorelbine for non-small cell lung cancer].
    Seto T.
    Nihon Rinsho; 2002 May 15; 60 Suppl 5():353-8. PubMed ID: 12101688
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients.
    Xu X, Ren H, Zhou B, Zhao Y, Yuan R, Ma R, Zhou H, Liu Z.
    Lung Cancer; 2012 Aug 15; 77(2):438-42. PubMed ID: 22516052
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.